Waldmann V, Jouven X, Narayanan K, Piot O, Chugh SS, Albert CM, et al. Association between atrial fibrillation and sudden cardiac death: pathophysiological and epidemiological insights. Circ Res. 2020;127:301–9. https://doi.org/10.1161/CIRCRESAHA.120.316756.

Article  CAS  PubMed  Google Scholar 

Zimetbaum P. Atrial Fibrillation [published correction appears in Ann Intern Med. 2017 Jun 20;166(12 ):920]. Ann Intern Med. (2017) 166:ITC33-ITC48. https://doi.org/10.7326/AITC201703070

Arbelo E, Dagres N. The 2020 ESC atrial fibrillation guidelines for atrial fibrillation catheter ablation, CABANA, and EAST. Europace. 2022;24(Suppl 2):ii3–7. https://doi.org/10.1093/europace/euab332.

Article  PubMed  Google Scholar 

Santhanakrishnan R, Wang N, Larson MG, Magnani JW, McManus DD, Lubitz SA, et al. Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction. Circulation. 2016;133:484–92. https://doi.org/10.1161/CIRCULATIONAHA.115.018614.

Article  PubMed  PubMed Central  Google Scholar 

Healey JS, Amit G, Field TS. Atrial fibrillation and stroke: how much atrial fibrillation is enough to cause a stroke? Curr Opin Neurol. 2020;33:17–23. https://doi.org/10.1097/WCO.0000000000000780.

Article  PubMed  Google Scholar 

Bruins Slot KM, Berge E. Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation. Cochrane Database Syst Rev. 2018;3(3):CD008980. https://doi.org/10.1002/14651858.CD008980.pub3.

Article  PubMed  Google Scholar 

Staerk L, Sherer JA, Ko D, Benjamin EJ, Helm RH. Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes. Circ Res. 2017;120:1501–17. https://doi.org/10.1161/CIRCRESAHA.117.309732.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lopes RD, Rordorf R, De Ferrari GM, Leonardi S, Thomas L, Wojdyla DM, et al. Digoxin and mortality in patients with atrial fibrillation. J Am Coll Cardiol. 2018;71:1063–74. https://doi.org/10.1016/j.jacc.2017.12.060.

Article  CAS  PubMed  Google Scholar 

Wong CX, Brooks AG, Leong DP, Roberts-Thomson KC, Sanders P. The increasing burden of atrial fibrillation compared with heart failure and myocardial infarction: a 15-year study of all hospitalizations in Australia. Arch Intern Med. 2012;172:739–41. https://doi.org/10.1001/archinternmed.2012.878.

Article  PubMed  Google Scholar 

Şaylık F, Çınar T, Akbulut T, Hayıroğlu Mİ. Comparison of catheter ablation and medical therapy for atrial fibrillation in heart failure patients: a meta-analysis of randomized controlled trials [published online ahead of print, 2022 Sep 6]. Heart Lung. 2022;57:69–74.

Article  PubMed  Google Scholar 

January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation. 2014;130:2071–104. https://doi.org/10.1161/CIR.0000000000000040.

Article  PubMed  Google Scholar 

Verma A, Jiang CY, Betts TR, Chen J, Deisenhofer I, Mantovan R, et al. Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med. 2015;372:1812–22. https://doi.org/10.1056/NEJMoa1408288.

Article  PubMed  Google Scholar 

Link MS, Haïssaguerre M, Natale A. Ablation of atrial fibrillation: patient selection, periprocedural anticoagulation, techniques, and preventive measures after ablation. Circulation. 2016;134:339–52. https://doi.org/10.1161/CIRCULATIONAHA.116.021727.

Article  CAS  PubMed  Google Scholar 

Jiang Q, Wang K, Shi J, Li M, Chen M. No association between alcohol consumption and risk of atrial fibrillation: a two-sample Mendelian randomization study. Nutr Metab Cardiovasc Dis. 2020;30:1389–96. https://doi.org/10.1016/j.numecd.2020.04.014.

Article  CAS  PubMed  Google Scholar 

Tousoulis D. Biomarkers in atrial fibrillation; from pathophysiology to diagnosis and treatment. Curr Med Chem. 2019;26:762–4. https://doi.org/10.2174/092986732605190422092911.

Article  CAS  PubMed  Google Scholar 

Cochran BJ, Ong KL, Manandhar B, Rye KA. APOA1: a protein with multiple therapeutic functions. Curr Atheroscler Rep. 2021;23:11. https://doi.org/10.1007/s11883-021-00906-7.

Article  CAS  PubMed  Google Scholar 

Flores R, Jin X, Chang J, Zhang C, Cogan DG, Schaefer EJ, et al. LCAT, ApoD, and ApoA1 Expression and Review of Cholesterol Deposition in the Cornea. Biomolecules. 2019;9:785. https://doi.org/10.3390/biom9120785.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347:1557–65. https://doi.org/10.1056/NEJMoa021993.

Article  CAS  PubMed  Google Scholar 

Schlitt A, Blankenberg S, Bickel C, Meyer J, Hafner G, Jiang XC, et al. Prognostic value of lipoproteins and their relation to inflammatory markers among patients with coronary artery disease. Int J Cardiol. 2005;102:477–85. https://doi.org/10.1016/j.ijcard.2004.05.056.

Article  PubMed  Google Scholar 

Bermudez EA, Rifai N, Buring J, Manson JE, Ridker PM. Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol. 2002;22:1668–73. https://doi.org/10.1161/01.atv.0000029781.31325.66.

Article  CAS  PubMed  Google Scholar 

Trieb M, Kornej J, Knuplez E, Hindricks G, Thiele H, Sommer P, et al. Atrial fibrillation is associated with alterations in HDL function, metabolism, and particle number. Basic Res Cardiol. 2019;114:27. https://doi.org/10.1007/s00395-019-0735-0.

Article  CAS  PubMed  Google Scholar 

Harrison SL, Lane DA, Banach M, Mastej M, Kasperczyk S, Jóźwiak JJ, et al. Lipid levels, atrial fibrillation and the impact of age: Results from the LIPIDOGRAM2015 study. Atherosclerosis. 2020;312:16–22. https://doi.org/10.1016/j.atherosclerosis.2020.08.026.

Article  CAS  PubMed  Google Scholar 

Guan B, Li X, Xue W, Tse G, Waleed KB, Liu Y, et al. Blood lipid profiles and risk of atrial fibrillation: a systematic review and meta-analysis of cohort studies. J Clin Lipidol. 2020;14:133–42. https://doi.org/10.1016/j.jacl.2019.12.002.

Article  PubMed  Google Scholar 

Li ZZ, Du X, Guo XY, Tang RB, Jiang C, Liu N, et al. Association between blood lipid profiles and atrial fibrillation: a case-control study. Med Sci Monit. 2018;24:3903–8. https://doi.org/10.12659/MSM.907580.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li F, Du X, He L, Jiang C, Xia S, Ma C, et al. Relationship between serum lipid levels and ischemic stroke in patients with atrial fibrillation: a nested case-control study based on the China Atrial Fibrillation Registry. BMC Cardiovasc Disord. 2021;21:424. https://doi.org/10.1186/s12872-021-02237-6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li X, Gao L, Wang Z, Guan B, Guan X, Wang B, et al. Lipid profile and incidence of atrial fibrillation: a prospective cohort study in China. Clin Cardiol. 2018;41:314–20. https://doi.org/10.1002/clc.22864.

Article  PubMed  PubMed Central  Google Scholar 

Besler C, Lüscher TF, Landmesser U. Molecular mechanisms of vascular effects of High-density lipoprotein: alterations in cardiovascular disease. EMBO Mol Med. 2012;4:251–68. https://doi.org/10.1002/emmm.201200224.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chistiakov DA, Orekhov AN, Bobryshev YV. ApoA1 and ApoA1-specific self-antibodies in cardiovascular disease. Lab Invest. 2016;96:708–18. https://doi.org/10.1038/labinvest.2016.56.

Article  CAS  PubMed  Google Scholar 

Barter PJ, Nicholls S, Rye KA, Anantharamaiah GM, Navab M, Fogelman AM. Antiinflammatory properties of HDL. Circ Res. 2004;95:764–72. https://doi.org/10.1161/01.RES.0000146094.59640.13.

Article  CAS  PubMed  Google Scholar 

Nazir S, Jankowski V, Bender G, Zewinger S, Rye KA, van der Vorst EPC. Interaction between high-density lipoproteins and inflammation: Function matters more than concentration! Adv Drug Deliv Rev. 2020;159:94–119. https://doi.org/10.1016/j.addr.2020.10.006.

Article  CAS  PubMed  Google Scholar 

Tang WH, Wu Y, Mann S, Pepoy M, Shrestha K, Borowski AG, et al. Diminished antioxidant activity of high-density lipoprotein-associated proteins in systolic heart failure. Circ Heart Fail. 2011;4:59–64. https://doi.org/10.1161/CIRCHEARTFAILURE.110.958348.

Article  CAS  PubMed  Google Scholar 

Uchida G, Mino Y, Suzuki T, Ikeda JI, Suzuki T, Takenaka K, et al. Decomposition and oxidation of methionine and tryptophan following irradiation with a nonequilibrium plasma jet and applications for killing cancer cells [published correction appears in Sci Rep. 2019 Nov 27;9(1):18140]. Sci Rep. 2019;9:6625. https://doi.org/10.1038/s41598-019-42959-4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Torosantucci R, Schöneich C, Jiskoot W. Oxidation of therapeutic proteins and peptides: structural and biological consequences. Pharm Res. 2014;31:541–53. https://doi.org/10.1007/s11095-013-1199-9.

Article  CAS  PubMed  Google Scholar 

Huang Y, DiDonato JA, Levison BS, Schmitt D, Li L, Wu Y, et al. An abundant dysfunctional apolipoprotein A1 in human atheroma. Nat Med. 2014;20:193–203. https://doi.org/10.1038/nm.3459.

Article  CAS  PubMed  PubMed Central  Google Scholar